Cancer is one of the world’s leading causes of death affecting one in three of all people in Western countries. A recent WHO report highlights a 70% increase in the incidence of cancer worldwide from 14 million to 25 million people diagnosed with the disease each year over the next two decades.
In addition to the high cost of cancer ($1.16 trillion / year) the human suffering associated with the disease is great (WHO, 2017).
The ethos of Px HealthCare, is to put patients first and make a real difference to their lives and quality of life. Through OWise, our mission is to provide smart digital tools that support cancer patients from the moment of diagnosis.
Px has developed an accredited cancer specific, digital health platform that combines Patient-Experience with Advanced Real World Data Science to improve clinical outcomes in oncology.
to improve patients’ experience of treatment and their clinical outcomes with personalized, medical mobile support tools. Helping them to be well informed and regain control.
to deliver global or national insights Patient Reported Outcomes improving the understanding of treatment effectiveness and experience. We conduct real world medical research at scale through our accredited apps that are already in the hands of patients.
to provide a real time monitoring platform for clinicians, improving outcomes, treatment adherence and delivering cost savings.
OWise breast is the accredited and clinically validated mobile app and website that helps you regain control of your life from the first day of a breast cancer diagnosis. OWise provides safe, reliable and credible information as well as practical support and guidance.
You can monitor and share changes of your day-to-day wellbeing, side effects and symptoms with your care team or other trusted individuals. This way you can help your doctors to make timely and informed decisions on how to give you more personalised care.
OWise prostate cancer has been developed to give personalized support to those with prostate cancer. OWise is your own personal cancer support app to help you regain control of your life from the first day of diagnosis. Let OWise support you with safe and reliable information while collating valuable insights about your day-to-day wellbeing that can assist your medical team in making informed decisions about on-going treatment.
Established by medical scientists in 2012 (Amsterdam, the Netherlands) and headquartered in London (UK).
Founder Dr. Anne Bruinvels has devoted much of her international career to the development of more effective, personalized drug treatments and diagnostic tools.
She previously founded and exited a data-mining biotechnology company (Curidium, which was listed on London Stock Exchange).
Dr. David Bruinvels (Medical Director and Anne’s brother) is an occupational physician specialized in oncology in addition to being a qualified epidemiologist.
